Literature DB >> 1157037

The management of Hodgkin's disease.

H S Kaplan, S A Rosenberg.   

Abstract

This paper presents a destillation of the authors' current views concerning the optimal management of Hodgkin's disease in relation to site(s) and stage of disease, constitutional symptoms, histopathology, and prior treatment, based on experience with a series of controlled clinical trials under way at Stanford University Medical Center since 1962.

Entities:  

Mesh：

Substances：

Year:  1975        PMID： 1157037     DOI： 10.1002/1097-0142(197508)36:2+<796::aid-cncr2820360825>3.0.co;2-n

Source DB:  PubMed          Journal:  Cancer        ISSN： 0008-543X            Impact factor:   6.860


  13 in total

Review 1.  [Hodgkin's disease. Results in diagnosis and treatment (author's transl)].

Authors:  D Huhn; W Wilmanns
Journal:  Klin Wochenschr       Date:  1979-04-17

Review 2.  Laetrile.

Authors:  J P Lewis
Journal:  West J Med       Date:  1977-07

3.  Cost of outpatient chemotherapy.

Authors:  K C Calman; J G McVie; M Soukop; M Richardson; J Donald
Journal:  Br Med J       Date:  1978-02-25

4.  [A modified MOPP regimen in the treatment of Hodgkin's disease stage III B and IV (author's transl)].

Authors:  F J Tigges; E Hiller; R M Schmülling; H D Waller; K Wilms
Journal:  Blut       Date:  1978-08-15

5.  Changing priorities in Hodgkin's disease.

Authors:  C J Williams
Journal:  Br Med J       Date:  1980-05-31

6.  Medical staff conference: Hodgkin disease.

Authors: 
Journal:  West J Med       Date:  1977-12

7.  [Diagnostic value of clinical methods in the staging of abdominal Hodgkin's disease (author's transl)].

Authors:  S L Roth; H Dombrowski; W D Gassel; F Hess; K Joseph; D Maroske; K P Riester; P Schmitz-Moormann; W B Schwerk; K Havemann
Journal:  Blut       Date:  1980-02

8.  Malignant lymphomas: results and observations from St George's Hospital.

Authors:  R Lee; M F Tungekar; C L Harmer; M S Rose
Journal:  Postgrad Med J       Date:  1981-07       Impact factor: 2.401

9.  A randomised study of adjuvant chemotherapy after mantle radiotherapy in supradiaphragmatic Hodgkin's disease PS IA-IIB: a report from the Manchester lymphoma group.

Authors:  H Anderson; D P Deakin; J Wagstaff; J M Jones; I D Todd; P M Wilkinson; R D James; W P Steward; G Blackledge; J H Scarffe
Journal:  Br J Cancer       Date:  1984-06       Impact factor: 7.640

10.  Serum immunoglobulins G, A, M, D and E concentrations in lymphomas.

Authors:  P L Amlot; L Green
Journal:  Br J Cancer       Date:  1979-09       Impact factor: 7.640
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.